FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/05/033366 [Registered on: 04/05/2021] Trial Registered Prospectively
Last Modified On:
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [N/AP]  
Study Design  Single Arm Study 
Public Title of Study   Safety assessment of products on skin 
Scientific Title of Study   Evaluation of irritation potential of skin care and hair care formulations on healthy human subjects  
Trial Acronym  N/AP 
Secondary IDs if Any  
Secondary ID  Identifier 
D01-6Q14-KD-MH21; Version: 01; Dated: 02/04/2021   Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Raji Patil  
Designation  Investigator  
Affiliation  Mascot Spincontrol India Pvt. Ltd.  
Address  3rd Floor, Kohinoor Estate, Sun Mill compound, Lower Parel.

Mumbai (Suburban)
MAHARASHTRA
400013
India 
Phone  022-43349191   
Fax    
Email  raji@mascotspincontrol.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Raji Patil  
Designation  Investigator  
Affiliation  Mascot Spincontrol India Pvt. Ltd.  
Address  3rd Floor, Kohinoor Estate, Sun Mill compound, Lower Parel.


MAHARASHTRA
400013
India 
Phone  022-43349191   
Fax    
Email  raji@mascotspincontrol.in  
 
Details of Contact Person
Public Query
 
Name  Mr Mohit Lalvani  
Designation  Study Director 
Affiliation  Mascot Spincontrol India Pvt. Ltd.  
Address  3rd Floor, Kohinoor Estate, Sun Mill compound, Lower Parel.

Mumbai (Suburban)
MAHARASHTRA
400013
India 
Phone  022-43349191   
Fax    
Email  mohit@mascotspincontrol.in  
 
Source of Monetary or Material Support  
Not Applicable 
 
Primary Sponsor  
Name  Kama Ayurveda Pvt Ltd  
Address  3 K Commercial Circle, Jungpura Extension, New Delhi – 110014  
Type of Sponsor  Other [FMCG] 
 
Details of Secondary Sponsor  
Name  Address 
Not Applicable  Not Applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Raji Patil  Mascot Spincontrol India Pvt. Ltd.   3rd Floor, Kohinoor Estate, Sun Mill compound, Lower Parel,
Mumbai (Suburban)
MAHARASHTRA 
022-43349191

raji@mascotspincontrol.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethos- An Institutional Ethics committee (Mumbai)   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Normal skin type  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  EHAFC (EHAFCT-002) : Product A RBANC (RSBNCT-001) : Product B KBAFS (KBAFST-001) : Product C RJHCL (RJHCT-001) : Product D  For Product, A, B and C Measure 0.04 ml (40 μl) of test samples with the help of 1 ml syringe. Transfer the test products on previously numbered Aluminium Finn Chamber, with the help of 1 ml syringe. The Finn chambers with the loaded products will then be taped onto the back of subjects. For Product D: 8% w/w solution of the investigational product will be prepared by weighing 2g of the product and dissolving it in distilled water and making up the final weight to 25g. 0.04 ml or 40 μl of the prepared sample will be loaded onto the filter paper disc with the help of 1 ml Micropipette. The Finn chamber with the product loaded filter paper discs will then be taped onto the back of subjects. 
Comparator Agent  Isotonic Solution: Negative Control SLS: Positive Control   For Negative Control: 40 μl of 0.9% Isotonic Saline Solution is transferred to previously numbered Aluminium Finn Chamber with an appropriate sized disk of Whatman no. 3 filter paper with the help of Micropipette. For Positive Control: Sodium Lauryl Sulphate solution: 1% w/w solution of SLS in distilled water will be prepared. •0.04 ml or 40 μl of the SLS solution will be loaded onto a Whatman filter paper disc, placed in clean Aluminum Finn Chamber. The Finn chamber with the loaded 0.9% Isotonic Saline solution will be taped onto the back of subjects 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
Subjects willing to come for regular follow up and ready to follow instructions during the study period. 
 
ExclusionCriteria 
Details  For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic, Being asthmatic, Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing
(whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Safety assessment of products  0 hrs, 24 hrs & 7 days  
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="24"
Sample Size from India="24" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/05/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="10" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Single Application Closed Patch test is conducted to measure the irritation potential of cosmetic products on the skin

Objective: To evaluate the irritation potential on healthy human subjects of Skin and Hair Care Formulations.

Duration of study: 8 days study

Kinetics: T0 (Evaluation of test sites by Dermatologist, Patch application)

                  T1(Patch removal, Evaluation of test sites by Dermatologist

                 T2(Evaluation of test sites by Dermatologist and Subject post 24 hrs of patch removal),                   

T8 (Evaluation of test sites by Dermat and Subject post 1 week of patch removal and tracking the positive cases)

Population 24 healthy subjects (12 males + 12 females)

The test area is checked for erythema and oedema caused due to the products and compared with positive control.

 
Close